This study is in progress, not accepting new patients
CLCZ696B2319E1 OL Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF
Summary
- Eligibility
- for people ages 1-18 (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Novartis Pharmaceuticals
- ID
- NCT03785405
- Phase
- Phase 3 Heart Failure Research Study
- Study Type
- Interventional
- Participants
- About 216 people participating
- Last Updated